Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Tramadol moves closer to Schedule 3 status

Tramadol is to be placed in Schedule 3 of the Misuse of Drugs Regulations 2001 when it becomes a controlled substance later this year (2014), the Government has revealed. However, it will be exempt from safe custody requirements. The Government has also decided that the current exemptions to prescriptions for temazepam, a Schedule 3 drug, are no longer warranted, but this decision will be subject to advice from the Advisory Council on the Misuse of Drugs. The announcement comes alongside publication of responses to a consultation on the topic.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11135837

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.

    £35.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Yellow and green capsules (FengYu/Dreamstime.com)

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.